Fastic en es it fr

Fastic Brand names, Fastic Analogs

Fastic Brand Names Mixture

  • No information avaliable

Fastic Chemical_Formula


Fastic RX_link

Fastic fda sheet

Fastic FDA

Fastic msds (material safety sheet)

Fastic Synthesis Reference

No information avaliable

Fastic Molecular Weight

317.423 g/mol

Fastic Melting Point

No information avaliable

Fastic H2O Solubility

Practically insoluble

Fastic State


Fastic LogP


Fastic Dosage Forms

Tablets (60, 120 mg)

Fastic Indication

For use as monotherapy to lower blood glucose in patients with Type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM) whose hyperglycemia cannot be adequately controlled by diet and physical exercise and who have not been chronically treated with other anti-diabetic agents. Also indicated for use in combination with metformin.

Fastic Pharmacology

Nateglinide is an amino-acid derivative that lowers blood glucose levels by stimulating insulin secretion from the pancreas. This action is dependent upon functioning beta-cells in the pancreatic islets.

Fastic Absorption

Rapidly absorbed following oral administration prior to a meal, absolute bioavailability is estimated to be approximately 73%.

Fastic side effects and Toxicity

An overdose may result in an exaggerated glucose-lowering effect with the development of hypoglycemic symptoms.

Fastic Patient Information

Fastic Organisms Affected

Humans and other mammals